The John Paul II Medical Research Institute has launched its "Campaign for Cures", a medical research program to create ethically non-controversial new human cell lines for the bio-manufacturing of vaccines, protein therapeutics, gene therapy and cell therapy. The goal of the campaign is to offer new ethical human cell lines that will replace aborted fetal cell lines currently used in bio-manufacturing.